ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,285
0,00%
Bitcoin
98 835,79
0,16%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Q32 Bio Inc (QTTB)

  7. Q32 Bio Inc (QTTB) Actualités

QTTB

Q32 Bio (QTTB)

Q32 Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:QTTB
DateHeureSourceTitreSymboleSociété
11/12/202413h07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
11/12/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
10/12/202422h05PR Newswire (US)Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development ProgramNASDAQ:QTTBQ32 Bio Inc
07/11/202413h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
07/11/202412h59PR Newswire (US)Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
05/11/202412h59PR Newswire (US)Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNASDAQ:QTTBQ32 Bio Inc
17/10/202402h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
14/10/202412h59PR Newswire (US)Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024NASDAQ:QTTBQ32 Bio Inc
29/08/202412h59PR Newswire (US)Q32 Bio to Participate in Upcoming September Investor ConferencesNASDAQ:QTTBQ32 Bio Inc
09/07/202412h59PR Newswire (US)Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic DermatitisNASDAQ:QTTBQ32 Bio Inc
01/07/202412h59PR Newswire (US)Q32 Bio Joins Russell 3000® IndexNASDAQ:QTTBQ32 Bio Inc
31/05/202422h25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTTBQ32 Bio Inc
09/05/202412h59PR Newswire (US)Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
03/04/202413h00PR Newswire (US)Q32 Bio Appoints Lee Kalowski as President & Chief Financial OfficerNASDAQ:QTTBQ32 Bio Inc
 Showing the most relevant articles for your search:NASDAQ:QTTB

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
LR
Legrand
EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
BEL20
Bel 20
EU
ML
Michelin
NYSE
KO
Coca Cola
EU
HO
Thales
NASDAQ
GOOGL
Alphabet
EU
PX1
CAC 40
NASDAQ
AAPL
Apple
COIN
XRPUSD
Ripple
FTSE
UKX
FTSE 100
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés